Thank you for joining us for our recent Myriad Genetics Investor Day

Watch the recording of the event, which highlighted our strategic roadmap and the catalysts for our continued growth and success.

Watch the video

Events & Presentations

View all events

Financial Reports and Filings

Date Filing Title Downloads
09/27/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/27/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/27/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/27/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/27/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/22/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/22/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/22/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
08/28/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
08/14/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
View all filings

Latest News

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood Thumbnail

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

Sep 28, 2023 | Products

Read more
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials Thumbnail

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

Sep 19, 2023 | Products

Read more
Myriad Genetics Issues 2022 Environmental, Social and Governance Report Thumbnail

Myriad Genetics Issues 2022 Environmental, Social and Governance Report

Sep 19, 2023 | Corporate

Read more
View all news releases

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

Read our ESG report
“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

Read our ESG report
“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics